kirkfoidslayer67
Iron
- Joined
- Jan 12, 2026
- Posts
- 56
- Reputation
- 45
Cheap FGFR3 Inhibition: You Do Not Need to Spend thousands on mainstream FGFR3 inhibitors
FGFR3 is very important for how our bones and cartilage grow. It helps control how our bones form, which means it can stop our bones from growing much.
Because of this people have been studying drugs that can stop FGFR3 from working. One example is Infigratinib, which is used to treat cancer (And to ascend you).
The problem is that these drugs are extremely expensive. They can cost between fifteen thousand dollars and twenty thousand dollars per month which's just too much money for most people to pay.
If you read about the science behind these drugs you will find something
An FGFR Inhibitor: PD173074
A long time ago before we had modern FGFR inhibitors scientists were already using a compound called PD173074.
PD173074 is a molecule that stops FGFR1 and FGFR3 from working. It does this by binding to a part of the FGFR3, which's important for how it works. In experiments PD173074 is very good at stopping FGFR3.
Many scientists have used PD173074 to study how FGFR3 works. They have used it to see how FGFR3 is involved in how our bones and cartilage grow.
In words scientists have been studying FGFR3 inhibition with PD173074 for a long time even before the expensive drugs like Infigratinib were made.
Why It Never Became a Drug
Even though PD173074 is very good at stopping FGFR3 in experiments it was never made into a medicine. There are a reasons for this:
- it does not work well in the body
- it is not specific enough
- pharmaceutical companies made newer and better inhibitors
That is why newer drugs like Infigratinib, Erdafitinib and Futibatinib were used instead of PD173074.
Important Disclaimer
PD173074 is only sold for use in research. It is meant to be used in experiments like growing cells in a lab.
It is not approved as a medicine. There are no studies to show if it is safe for people to use. Because of this we should only talk about PD173074 in the context of research not for use.
Conclusion:
If you’re too broke to afford mainstream FGFR3 Inhibitors you may have a look into this. If you have the finances for the real stuff, that’s probably better for you - but no medical advice of course.
FGFR3 is very important for how our bones and cartilage grow. It helps control how our bones form, which means it can stop our bones from growing much.
Because of this people have been studying drugs that can stop FGFR3 from working. One example is Infigratinib, which is used to treat cancer (And to ascend you).
The problem is that these drugs are extremely expensive. They can cost between fifteen thousand dollars and twenty thousand dollars per month which's just too much money for most people to pay.
If you read about the science behind these drugs you will find something
An FGFR Inhibitor: PD173074
A long time ago before we had modern FGFR inhibitors scientists were already using a compound called PD173074.
PD173074 is a molecule that stops FGFR1 and FGFR3 from working. It does this by binding to a part of the FGFR3, which's important for how it works. In experiments PD173074 is very good at stopping FGFR3.
Many scientists have used PD173074 to study how FGFR3 works. They have used it to see how FGFR3 is involved in how our bones and cartilage grow.
In words scientists have been studying FGFR3 inhibition with PD173074 for a long time even before the expensive drugs like Infigratinib were made.
Why It Never Became a Drug
Even though PD173074 is very good at stopping FGFR3 in experiments it was never made into a medicine. There are a reasons for this:
- it does not work well in the body
- it is not specific enough
- pharmaceutical companies made newer and better inhibitors
That is why newer drugs like Infigratinib, Erdafitinib and Futibatinib were used instead of PD173074.
Important Disclaimer
PD173074 is only sold for use in research. It is meant to be used in experiments like growing cells in a lab.
It is not approved as a medicine. There are no studies to show if it is safe for people to use. Because of this we should only talk about PD173074 in the context of research not for use.
Conclusion:
If you’re too broke to afford mainstream FGFR3 Inhibitors you may have a look into this. If you have the finances for the real stuff, that’s probably better for you - but no medical advice of course.
. plus when your running something like erda or infig you cannot get maximum potential out of the drug (max inhibiton on fgfr3) without sides. as far as i remember infig > erda because erda went too hard on fgfr4 (correct me if im wrong) still both drugs hit fgfr1and2 at the same strenght as fgfr3 so again you cannot go nuclear without sides. and yes you need to make sure your fgfr1 isnt nuked too much
